Related Articles
Characterization of highly proliferative secondary tumor clusters along host blood vessels in malignant glioma
Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts
VEGFR and EGFR inhibition increases epithelial cellular characteristics and chemotherapy sensitivity in mesenchymal bladder cancer cells
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer
MicroRNA-103 suppresses glioma cell proliferation and invasion by targeting the brain-derived neurotrophic factor